STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVC
  4. [Form 4] ENTRAVISION COMMUNICATIONS CORP Insider Trading Activity

EVC President & COO reports stock sales and major equity awards

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Entravision Communications Corp (EVC) insider activity shows its President and COO, through a family trust, selling Class A common stock under a pre-arranged Rule 10b5-1 trading plan. On November 21, 2025, the trust sold 39,238 shares at a weighted average price of $2.6678, followed by 20,121 shares at $2.7351 on November 24 and 15,913 shares at $2.7095 on November 25, for total reported sales of 75,272 shares.

After these trades, the family trust beneficially owns 418,998 shares of Class A common stock, while an additional 504,500 restricted stock units are reported as directly owned. The officer also holds performance units covering 230,000 shares vesting through January 21, 2030 and 100,000 shares vesting through January 25, 2029, which combine time-based vesting with market-based total shareholder return hurdles.

Positive

  • None.

Negative

  • None.
Insider JEFFERY LIBERMAN A
Role President and COO
Sold 75,272 shs ($203K)
Type Security Shares Price Value
Sale Class A common stock 15,913 $2.7095 $43K
Sale Class A common stock 20,121 $2.7351 $55K
Sale Class A common stock 39,238 $2.6678 $105K
holding Performance Units -- -- --
holding Performance Units -- -- --
holding Class A common stock -- -- --
Holdings After Transaction: Class A common stock — 403,085 shares (Indirect, By family trust); Performance Units — 230,000 shares (Direct); Class A common stock — 504,500 shares (Direct)
Footnotes (1)
  1. Transaction represents a sale of shares of Class A common stock effected pursuant to a Rule 10b5-1 trading plan. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.56 to $2.74, inclusive. The Reporting Person undertakes to provide to Entravision Communications Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.685 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.695 to $2.7488, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Includes 504,500 restricted stock units. Each Performance Unit represents a contingent right to receive one share of the Issuer's Class A common stock upon vesting. The Performance Units vest by a combination of both (i) time-based vesting, with 20% vesting on January 21, 2026 and 10% vesting every six months thereafter in eight equal installments, and (ii) a market-based vesting condition based on total shareholder return hurdles in four equal tranches. Each Performance Unit represents a contingent right to receive one share of the Issuer's Class A common stock upon vesting. The Performance Units vest by a combination of both (i) time-based vesting, with 20% vesting on January 25, 2025 and 10% vesting every six months thereafter in eight equal installments, and (ii) a market-based vesting condition based on total shareholder return hurdles in four equal tranches.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JEFFERY LIBERMAN A
(Last) (First) (Middle)
C/O ENTRAVISION COMMUNICATIONS CORP
1 ESTRELLA WAY
(Street)
BURBANK CA 91504
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ENTRAVISION COMMUNICATIONS CORP [ EVC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and COO
3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A common stock 11/21/2025 S(1) 39,238 D $2.6678(2) 439,119 I By family trust
Class A common stock 11/24/2025 S(1) 20,121 D $2.7351(3) 418,998 I By family trust
Class A common stock 11/25/2025 S(1) 15,913 D $2.7095(4) 403,085 I By family trust
Class A common stock 504,500(5) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Units (6) (6) 01/21/2030 Class A common stock 230,000 230,000 D
Performance Units (7) (7) 01/25/2029 Class A common stock 100,000 100,000 D
Explanation of Responses:
1. Transaction represents a sale of shares of Class A common stock effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.56 to $2.74, inclusive. The Reporting Person undertakes to provide to Entravision Communications Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.685 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.695 to $2.7488, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
5. Includes 504,500 restricted stock units.
6. Each Performance Unit represents a contingent right to receive one share of the Issuer's Class A common stock upon vesting. The Performance Units vest by a combination of both (i) time-based vesting, with 20% vesting on January 21, 2026 and 10% vesting every six months thereafter in eight equal installments, and (ii) a market-based vesting condition based on total shareholder return hurdles in four equal tranches.
7. Each Performance Unit represents a contingent right to receive one share of the Issuer's Class A common stock upon vesting. The Performance Units vest by a combination of both (i) time-based vesting, with 20% vesting on January 25, 2025 and 10% vesting every six months thereafter in eight equal installments, and (ii) a market-based vesting condition based on total shareholder return hurdles in four equal tranches.
/s/ Jeffrey C. DeMartino by power of attorney for Jeffery A. Liberman 11/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions were reported in this Form 4 for Entravision (EVC)?

The President and COO, through a family trust, reported three sales of Class A common stock: 39,238 shares at $2.6678 on November 21, 2025, 20,121 shares at $2.7351 on November 24, and 15,913 shares at $2.7095 on November 25.

Were the Entravision (EVC) insider sales made under a Rule 10b5-1 plan?

Yes. The filing states that the transactions represent sales of Class A common stock effected pursuant to a Rule 10b5-1 trading plan, which is a pre-arranged trading program.

How many Entravision (EVC) shares does the reporting person own after these transactions?

Following the reported sales, the family trust beneficially owns 418,998 shares of Entravision Class A common stock, and there are also 504,500 restricted stock units reported as beneficially owned.

What derivative equity awards does the Entravision (EVC) insider hold?

The reporting person holds performance units representing 230,000 shares of Class A common stock vesting through January 21, 2030 and 100,000 shares vesting through January 25, 2029.

How do the Entravision (EVC) performance units vest for this insider?

Each performance unit gives a contingent right to one share. Vesting combines time-based vesting—20% on the initial vesting date and 10% every six months in eight equal installments—with a market-based vesting condition tied to total shareholder return hurdles in four equal tranches.

What role does the reporting person hold at Entravision (EVC)?

The reporting person is identified as an officer of Entravision Communications Corp, serving as President and COO.